These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 27448970)
1. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer. Han D; Wu J; Han Y; Wei M; Han S; Lin R; Sun Z; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Wen W; Qin W Oncotarget; 2016 Sep; 7(37):59471-59481. PubMed ID: 27448970 [TBL] [Abstract][Full Text] [Related]
2. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth. Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065 [TBL] [Abstract][Full Text] [Related]
3. A Novel Fully Human Antibody targeting Extracellular Domain of PSMA Inhibits Tumor Growth in Prostate Cancer. Wu J; Han D; Shi S; Zhang Q; Zheng G; Wei M; Han Y; Li G; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Qin W; Wen W Mol Cancer Ther; 2019 Jul; 18(7):1289-1301. PubMed ID: 31048359 [TBL] [Abstract][Full Text] [Related]
4. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer. Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460 [TBL] [Abstract][Full Text] [Related]
5. Anti-PSMA Frigerio B; Morlino S; Luison E; Seregni E; Lorenzoni A; Satta A; Valdagni R; Bogni A; Chiesa C; Mira M; Canevari S; Alessi A; Figini M J Exp Clin Cancer Res; 2019 Jul; 38(1):326. PubMed ID: 31337429 [TBL] [Abstract][Full Text] [Related]
6. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody. Fortmüller K; Alt K; Gierschner D; Wolf P; Baum V; Freudenberg N; Wetterauer U; Elsässer-Beile U; Bühler P Prostate; 2011 May; 71(6):588-96. PubMed ID: 20945402 [TBL] [Abstract][Full Text] [Related]
7. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging. Frigerio B; Franssen G; Luison E; Satta A; Seregni E; Colombatti M; Fracasso G; Valdagni R; Mezzanzanica D; Boerman O; Canevari S; Figini M Oncotarget; 2017 Feb; 8(7):10919-10930. PubMed ID: 28051996 [TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe. Mazzocco C; Fracasso G; Germain-Genevois C; Dugot-Senant N; Figini M; Colombatti M; Grenier N; Couillaud F Sci Rep; 2016 Mar; 6():23314. PubMed ID: 26996325 [TBL] [Abstract][Full Text] [Related]
9. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535 [TBL] [Abstract][Full Text] [Related]
10. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody. Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882 [TBL] [Abstract][Full Text] [Related]
11. A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer. Frigerio B; Fracasso G; Luison E; Cingarlini S; Mortarino M; Coliva A; Seregni E; Bombardieri E; Zuccolotto G; Rosato A; Colombatti M; Canevari S; Figini M Eur J Cancer; 2013 Jun; 49(9):2223-32. PubMed ID: 23433847 [TBL] [Abstract][Full Text] [Related]
12. Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization. Novakova Z; Belousova N; Foss CA; Havlinova B; Gresova M; Das G; Lisok A; Prada A; Barinkova M; Hubalek M; Pomper MG; Barinka C Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932591 [TBL] [Abstract][Full Text] [Related]
13. Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen. Frigerio B; Benigni F; Luison E; Seregni E; Pascali C; Fracasso G; Morlino S; Valdagni R; Mezzanzanica D; Canevari S; Figini M Immunol Lett; 2015 Nov; 168(1):105-10. PubMed ID: 26404855 [TBL] [Abstract][Full Text] [Related]
14. A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigen. Nawaz S; Mullen GED; Blower PJ; Ballinger JR Nucl Med Commun; 2017 Aug; 38(8):666-671. PubMed ID: 28598898 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Huang X; Bennett M; Thorpe PE Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089 [TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer. Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748 [TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer. Wolf P; Alt K; Wetterauer D; Bühler P; Gierschner D; Katzenwadel A; Wetterauer U; Elsässer-Beile U J Immunother; 2010 Apr; 33(3):262-71. PubMed ID: 20445346 [TBL] [Abstract][Full Text] [Related]
18. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate. Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845 [TBL] [Abstract][Full Text] [Related]
19. PET imaging of Wong P; Li L; Chea J; Delgado MK; Crow D; Poku E; Szpikowska B; Bowles N; Channappa D; Colcher D; Wong JYC; Shively JE; Yazaki PJ Nucl Med Biol; 2017 Apr; 47():62-68. PubMed ID: 28126683 [TBL] [Abstract][Full Text] [Related]
20. Fully human antibody V Wang G; Zhou X; Fucà G; Dukhovlinova E; Shou P; Li H; Johnston C; Mcguinness B; Dotti G; Du H J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]